NCT01740739

Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors

Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors (Cardiac-CV)

• Status: Suspended
• Phase: —
• Study type: Observational
• Enrollment: 60 (estimated)
• Sponsor: Epic Research & Diagnostics, Inc. · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to explore the relationship between the ClearView scan results and a variety of cardiovascular risk indicators such as the Coronary Calcium Score, Framingham Risk Factors, Reynolds Risk Score, and biomarkers of inflammation. The ClearView device is a bio-electrographic tool that may assist medical professionals in rapid assessment of the systemic origin of the patient's presenting symptom(s). The ClearView is a potentially valuable resource that may benefit a physician's office by offering expedited differentiation capabilities. The subsequent results have the potential to include more data that would allow rapid patient diagnosis, triage, and treatment; optimized precious resource expenditure (nursing, physician, etc.); lower costs to facility, patient and insurance company; and decreased office wait time.

Conditions

• Cardiovascular Diseases
• Coronary Artery Disease

Timeline

• Start date: 2012-11-01
• Primary completion: 2013-06-01
• Completion: 2013-06-01
• First posted: 2012-12-04
• Last updated: 2013-06-14

Locations

1 site across 1 country: United States